Michael Andrew Wolfe

This profile gathers the share dealings of Michael Andrew Wolfe in Small Pharma Inc. (formerly, Unilock Capital Corp.). Over a trading history stretching from 29 April 2021 to 20 July 2022, the count stands at 6 filings.

Every open-market trade on record is a purchase: 5 purchases worth €21k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2022, the count stands at 3 purchases and no sales.

In size, the median ticket on the buying side is €2,896. No cluster: in 4 purchases, no other insider of the company bought within 30 days.

Most recently, on 20 July 2022, the filings show an open-market purchase worth €2,896 in Small Pharma Inc. (formerly, Unilock Capital Corp.). The median gap between trade and publication is zero days: most filings appear on the same day. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.